The primary outcome of this study is the detection of clinical relevant adenomas (>= 5mm) in the ileal pouch.
ID
Source
Brief title
Condition
- Gastrointestinal tract disorders congenital
- Malignant and unspecified neoplasms gastrointestinal NEC
- Gastrointestinal neoplasms benign
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome of this study is the detection of clinical relevant
adenomas (>= 5mm) in the ileal pouch.
Secondary outcome
Secondary outcomes include:
- Detection of advanced neoplasia in the ileal pouch, defined by advanced
adenoma (>=10mm and/or and adenoma with high-grade dysplasia) or cancer.
- Detection of adenomas 1-4mm, 5-9mm and >=10mm both in the pouch body and
rectal remnant with WLE, NBI and dye-based chromoendoscopy
- Number of performed polypectomies
- Chosen interval for next surveillance endoscopy
- Insight Polyposis Staging System (IPSS) score (10)
- Duration of examination
- Incidence of endoscopy-related complications
Background summary
Familial adenomatous polyposis (FAP) is an inherited gastrointestinal disorder
in which patients develop extensive polyps in the colon that, if left
untreated, lead to colon cancer. As a preventive measure, patients are
endoscopically monitored and the colon is typically removed before the age of
25. This operation can be performed with the possibility of either rectum
preservation via ileorectal/ileosigmoidal anastomisis or a pouch procedure.
However, polyps can still form in the pouch, remaining rectum, and upper
gastrointestinal tract after the operation.
Various modalities are utilized to surveil these patients, including
high-definition endoscopy, virtual chromoendoscopy, and dye chromoendoscopy.
While both virtual and dye chromoendoscopy have been proven effective in
detecting polyps, guidelines currently lack recommendations regarding the
preference for a particular modality, and some centers utilize both modalities.
This study aims to examine the difference in adenoma detection through the use
of these modalities. Adenomas can develop in the pouch, with the incidence of
cancer in the pouch being described as 1-2%. Optimizing endoscopic surveillance
techniques in FAP patients is crucial to 1) prevent the development of cancer
and 2) avoid the need for a pouch excision.
Study objective
The primary outcome of this study is the detection of clinical relevant
adenomas (>= 5mm) in the ileal pouch.
Study design
This study is designed as an international multi-center randomized controlled
trial with an estimated duration of 2 years. Patients will undergo their
scheduled regular surveillance pouchoscopy, performed by endoscopists with
experience with FAP. Prior to the endoscopy, patients will be randomly assigned
to undergo pouchoscopy with dye-based chromoendoscopy or with NBI/BLI (virtuel
chromoendoscopy). After diagnostic assessment, adenomas with an indication for
endoscopic intervention will be removed.
Intervention
Both interventions are standard care for detecting adenomas.
1. Virtual chromoendoscopy
2. Dye chromoendoscopy
Study burden and risks
Both interventions are standard care, and pouchoscopies are not scheduled more
frequently than previously agreed upon for the surveillance of FAP patients.
The standard risks of pouch endoscopy will be considered similar to the risks
of colonoscopy:
Gastrointestinal risks:
- Perforation occurs in 4 per 10,000 endoscopies
- Bleeding at biopsy or polypectomy site. A major haemorrhage occurs in 8 per
10,000
Non-gastrointestinal risks
- Sedation-related change in breathing, heart rate and blood pressure
- Pulmonary, cardiovascular, and cerebrovascular complications are rare and are
associated with an older age and increasing comorbidity
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
Diagnosis of FAP
- Genetic diagnosis: proven APC germline mutation
- Clinical diagnosis: >100 colorectal adenomas in combination with a positive
family history of FAP
Have an ileal-pouch anal anastomosis (IPAA)
- After primary proctocolectomy or
- secondary protectomy after initial colectomy with ileorectal or ileosigmoidal
anastomosis (IRA/ISA)
Age >= 18 years.
Exclusion criteria
Allergy to indigo carmine (fluid which is used with dye chromoendoscopy).
Patients who are unwilling or unable to give informed consent.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL84073.018.23 |